LTZ
Live / Registered — Registered (as of 15 Oct 2024)
What this means for you
Registered since 15 Oct 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97216996
- Registration number
- 7538041
- Mark type
- Design + words
- Filed
- 13 Jan 2022
- Published for opposition
- 29 Nov 2022
- Registered
- 15 Oct 2024
- Attorney of record
- Enshan Hong
Goods and services
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; discovery and development of novel therapeutics for the treatment of multiple diseases; discovery and development of novel therapeutics for treatment of cancer, autoimmune and infectious diseases
Owner
- LTZ Therapeutics Inc., Redwood City, CA, US
- LTZ Therapeutics Inc., Redwood City, CA, US
- LTZ Therapeutics Inc., Fremont, CA, US
Prosecution history
- 15 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
- 11 Sept 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Sept 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Sept 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Jul 2024 — USE AMENDMENT FILED
- 07 Sept 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Jul 2024 — TEAS STATEMENT OF USE RECEIVED
- 28 Feb 2024 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 05 Jan 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Jan 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Jan 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 02 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Oct 2023 — SOU EXTENSION 2 GRANTED
- 31 Oct 2023 — SOU EXTENSION 2 FILED